Stocksigma LogoStocksigma Logo

Anupam Rasayan Reports Revised Q2 FY27 Results Following Consolidated EPS Correction

Anupam Rasayan India Ltd. issued revised unaudited financial results for the quarter and half-year ended 30th Sep'26, rectifying an Excel formula error

Anupam Rasayan Reports Revised Q2 FY27 Results Following Consolidated EPS Correction

Anupam Rasayan India Ltd 路 Others (Uncategorized) 路 07 Nov 2026, 4:57 am

Anupam Rasayan Reports Revised Q2 FY27 Results Following Consolidated EPS Correction Anupam Rasayan India Ltd. issued revised unaudited financial results for the quarter and half-year ended 30th Sep'26, rectifying an Excel formula error where consolidated EPS previously factored total profit rather than profit attributable to owners. Revised consolidated basic and diluted EPS stand at INR 4.39 for the quarter and INR 7.79 for H1. Consolidated Q2 revenue from operations rose 10.19% YoY to INR 8,059.35m, while net profit attributable to owners increased 12.71% YoY to INR 500.34m. The firm consolidated Bliss GVS Pharma post acquiring a 50.07% stake on 28th Sep'26.

Original exchange filing (PDF)

More announcements from Anupam Rasayan India Ltd

All Anupam Rasayan India Ltd announcements